- ISIN
- US09060U5074
- CUSIP
- 09060U507
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Mar 14, 2008
Highlights
- Market Cap
- $4.78M
- Enterprise Value
- $4.65M
- EPS (TTM)
- -$0.84
- Gross Profit (TTM)
- -$1.66M
- EBITDA (TTM)
- -$5.25M
- Year Range
- $0.75 - $2.29
- ROA (TTM)
- -454.15%
- ROE (TTM)
- 729.36%
- Avg. Volume (1M)
- 360K
- Avg. Volume Value (1M)
- $331.13K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BCDA Performance Chart
BioCardia, Inc. (BCDA) is down 34.1% since the beginning of the year. At $1 per share, BCDA is trading 64.0% below its 52-week high of $2. Investors who bought $1,000 worth of BCDA shares 5 years ago would now be looking at an investment worth $17.
Loading charts...
Compare this symbol against anything
Returns By Period
BioCardia, Inc. (BCDA) has returned -34.06% so far this year and -61.31% over the past 12 months. Over the last ten years, BCDA has returned -26.24% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
BioCardia, Inc.
- 1D
- 6.89%
- 1M
- -31.32%
- 6M
- -32.99%
- YTD
- -34.06%
- 1Y
- -61.31%
- 3Y*
- -61.61%
- 5Y*
- -55.97%
- 10Y*
- -26.24%
- ALL TIME*
- -21.59%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
BCDA Monthly Returns History
Based on dividend-adjusted daily data since Sep 12, 2013, BCDA's average daily return is +0.36%, while the average monthly return is +5.94%. At this rate, an investment would double in approximately 1.0 years.
Historically, 40% of months were positive and 60% were negative. The best month was Nov 2017 with a return of +852.4%, while the worst month was Aug 2019 at -71.0%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.
On a daily basis, BCDA closed higher 38% of trading days. The best single day was Nov 30, 2017 with a return of +875.6%, while the worst single day was Aug 6, 2019 at -65.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.60% | 4.88% | -6.20% | -5.79% | -18.42% | 33.33% | -33.53% | -34.06% | |||||
| 2025 | 13.30% | -18.62% | 26.37% | 23.62% | -31.21% | -9.72% | 9.74% | -7.62% | -34.75% | 8.53% | 3.57% | -13.79% | -42.66% |
| 2024 | -31.77% | 21.36% | -26.00% | -4.89% | -20.43% | -35.71% | 1.35% | 1.33% | 2.30% | -25.32% | -2.15% | -4.39% | -78.12% |
| 2023 | 21.53% | -13.39% | -11.36% | 5.64% | -14.08% | 50.85% | -61.42% | -24.27% | -44.88% | -13.40% | 66.85% | 6.92% | -68.22% |
| 2022 | -4.64% | 11.89% | -0.00% | -25.60% | 9.09% | -13.69% | 0.00% | 37.24% | -2.51% | 0.52% | -5.13% | 12.97% | 7.73% |
| 2021 | 18.79% | -5.60% | 11.86% | -18.43% | 15.54% | -2.93% | -16.37% | -11.14% | 6.44% | -10.83% | -26.79% | -5.37% | -43.93% |
Benchmark Metrics
BioCardia, Inc. has an annualized alpha of 130.91%, beta of 0.44, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 12, 2013.
- This stock participated in 199.11% of S&P 500 Index downside but only 50.78% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.44 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 130.91%
- Beta
- 0.44
- R²
- 0.00
- Upside Capture
- 50.78%
- Downside Capture
- 199.11%
Return for Risk
Risk / Return Rank
BCDA ranks 9 for risk / return — above 9% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for BioCardia, Inc. (BCDA) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BCDA | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.20 | ||
| Sortino ratioReturn per unit of downside risk | -3.10 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.25 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | 2.00 | -2.94 |
| Martin ratioReturn relative to average drawdown | -1.37 | 8.49 | -9.86 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the BioCardia, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the BioCardia, Inc. was 99.86%, occurring on Jul 30, 2026. The portfolio has not yet recovered.
The current BioCardia, Inc. drawdown is 99.85%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.86%Jul 2026 | 8y 8mo | — | 8y 8moDec 2017 - now | — |
-72.03%Jun 2017 | 5mo 3d | 5mo 26d | 10mo 29dJan 2017 - Nov 2017 | — |
-64.71%Dec 2015 | 2y 1mo | 11mo 21d | 3y 25dOct 2013 - Nov 2016 | — |
-38.04%Dec 2016 | 2d | 20d | 22dNov 2016 - Dec 2016 | — |
-31.07%Oct 2013 | 24d | 4d | 28dSep 2013 - Oct 2013 | — |
Drawdown Indicators
| BCDA | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.86% | -56.78% | -43.08% |
Max Drawdown (1Y)Largest decline over 1 year | -66.03% | -9.10% | -56.93% |
Max Drawdown (3Y)Largest decline over 3 years | -95.20% | -18.90% | -76.30% |
Max Drawdown (5Y)Largest decline over 5 years | -98.56% | -25.43% | -73.13% |
Max Drawdown (10Y)Largest decline over 10 years | -99.86% | -33.92% | -65.94% |
Current DrawdownCurrent decline from peak | -99.85% | -1.58% | -98.27% |
Average DrawdownAverage peak-to-trough decline | -72.49% | -10.70% | -61.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.95% | 2.14% | +42.81% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of BioCardia, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how BioCardia, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BCDA
Add BioCardia, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BCDA